Source author record

Weimin Xiao

Weimin Xiao appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

2works
6topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2024arXiv

Limited Feedback on Measurements: Sharing a Codebook or a Generative Model?

Discrete Fourier transform (DFT) codebook-based solutions are well-established for limited feedback schemes in frequency division duplex (FDD) systems. In recent years, data-aided solutions have been shown to achieve higher performance, enabled by the adaptivity of the feedback scheme to the propagation environment of the base station (BS) cell. In particular, a versatile limited feedback scheme utilizing Gaussian mixture models (GMMs) was recently introduced. The scheme supports multi-user communications, exhibits low complexity, supports parallelization, and offers significant flexibility concerning various system parameters. Conceptually, a GMM captures environment knowledge and is subsequently transferred to the mobile terminals (MTs) for online inference of feedback information. Afterward, the BS designs precoders using either directional information or a generative modeling-based approach. A major shortcoming of recent works is that the assessed system performance is only evaluated through synthetic simulation data that is generally unable to fully characterize the features of real-world environments. It raises the question of how the GMM-based feedback scheme performs on real-world measurement data, especially compared to the well-established DFT-based solution. Our experiments reveal that the GMM-based feedback scheme tremendously improves the system performance measured in terms of sum-rate, allowing to deploy systems with fewer pilots or feedback bits.

preprint2013arXiv

MiRank: A bioinformatics tool for gene/miRNA ranking and pathway profiling with TCGA-KEGG data sets

The Cancer Genome Atlas (TCGA) provides researchers with clinicopathological data and genomic characterizations of various carcinomas. These data sets include expression microarrays for genes and microRNAs -- short, non-coding strands of RNA that downregulate gene expression through RNA interference -- as well as days_to_death and days_to_last_followup fields for each tumor sample. Our aim is to develop a software tool that screens TCGA data sets for genes/miRNAs with functional involvement in specific cancers. Furthermore, our computational pipeline is intended to produce a set of visualizations, or profiles, that place our screened outputs in a pathway-centric context. We accomplish our 'screening' by ranking genes/miRNAs by the correlation of their expression misregulation with differential patient survival. In other words, if a gene/miRNA is consistently misregulated in patients with poor survival rates and, on the other hand, is expressed more 'normally' in patients with longer survival rates, then it is ranked highly; if its misregulation has no such correlation with good/bad survival in patients, then its rank is low. Our pathway profiling pipeline produces several outputs, which allow us to examine the functional roles played by highly ranked genes discovered by our screening. Running the OV (ovarian serous cystadenocarcinoma) data set through our analysis pipeline, we find that several highly ranked pathways and functional groups of genes (VEGF, Jun, Fos, etc.) have already been shown to play some part in the development of epithelial ovarian carcinomas. We also observe that the dysfunction of the Wnt signaling pathway, which regulates cell-fate specification and progenitor cell differentiation, has a disproportionate impact on the survival of ovarian cancer patients.